Elevated PD-L1 and HER2 expression on aneuploid carcinoma cells in malignant ascites accelerate stumor cell immune evasion in gastrointestinal cancer patients

被引：0
|
作者：
Chen, Yang [1 ]
Qi, Changsong [1 ]
Yuan, JiaJia [1 ]
Liu, Dan [1 ]
Peng, Zhi [1 ]
Zhang, Xiaotian [1 ]
Li, Jian [1 ]
Lin, Pin Peter [2 ]
Li, Yilin [1 ]
Shen, Lin [1 ]
机构：
[1] Peking Univ, Canc Hosp, Beijing, Peoples R China
[2] Cytelligen, San Diego, CA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5381
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5381
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Immune cell score, PD-L1 expression and prognosis in esophageal cancer
    Junttila, Anna
    Vayrynen, Juha P.
    Ahtiainen, Maarit
    Kuopio, Teijo
    Mrena, Johanna
    Sihvo, Eero
    Helminen, Olli
    ACTA ONCOLOGICA, 2021, 60 (04) : 544 - 548
  • [42] Immune microenvironment features and efficacy of PD-1/PD-L1 blockade in non-small cell lung cancer patients with EGFR or HER2 exon 20 insertions
    Chen, Kaiyan
    Pan, Guoqiang
    Cheng, Guoping
    Zhang, Fanrong
    Xu, Yanjun
    Huang, Zhiyu
    Fan, Yun
    THORACIC CANCER, 2021, 12 (02) : 218 - 226
  • [43] Immune Microenvironment Features and Efficacy of PD-1/PD-L1 Blockade in Non-Small-Cell Lung Cancer Patients with EGFR or HER2 Exon 20 Insertions
    Chen, K.
    Xu, Y.
    Huang, Z.
    Yu, X.
    Fan, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S194 - S194
  • [44] PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma
    Sahinli, Hayriye
    Akyurek, Nalan
    Yilmaz, Mukaddes
    Kandemir, Olcay
    Duran, Ayse Ocak
    Kulacoglu, Sezer
    Ucar, Gokhan
    Acar, Elif
    Ozet, Ahmet
    Gumus, Mahmut
    Oksuzoglu, O. Berna C.
    Ozdemir, Nuriye Y.
    INDIAN JOURNAL OF CANCER, 2021, 58 (04) : 561 - 566
  • [45] PD-L1 Expression in Patients with Small Cell Lung Cancer
    Wang, Haiyue
    Li, Zhongwu
    Yang, Xin
    Zhou, Lixin
    Lin, Dongmei
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S818 - S818
  • [46] Prevalence of CLDN18.2, HER2 and PD-L1 in gastric cancer samples
    Moran, D.
    Maurus, D.
    Rohde, C.
    Arozullah, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [47] Aberrant PD-1/PD-L1 expression in immune cell subsets and elevated soluble PD-L1 levels in mutiple sclerosis patients correlate with disease activity and disability
    Tsaktanis, Thanos
    Mathias, Linnerbauer
    Lena, Losslein
    Hemmer, Bernhard
    Muehlau, Mark
    Schwab, Stefan
    Rothhammer, Veit
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 557 - 558
  • [48] PD-L1 expression on circulating tumor cells in patients with hepatocellular carcinoma
    Kim, Hee Yeon
    Kim, Chang Wook
    Kim, Sungkeun
    Kim, Ji Young
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 409 - 409
  • [49] The prognostic role of PD-L1 expression in tumor and immune cells in oral cavity squamous cell carcinoma
    Kutukova, S.
    Beliak, N.
    Manikhas, G.
    Raskin, G.
    Ivaskova, Y.
    Popova, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder
    Kim, Donghyun
    Kim, Jin Man
    Kim, Jun-Sang
    Kim, Sup
    Kim, Kyung-Hee
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
12345